Heads up: some links below are affiliate links — assume any provider we list may compensate us, at no cost to you. It never buys a better score, but the providers we work with are listed first. See our affiliate disclosure.
Head-to-head
CoreAge Rx vs MultiMedRx
CoreAge Rx and MultiMedRx both offer GLP-1 telehealth, but they make different trade-offs on speed to first dose, flat pricing, access and molecule choice. Here they are side-by-side on the Rx-Readiness Score — our readiness rubric.
CoreAge Rx
Higher scoreRanked #1 · Grade A
Best for: Working moms who want a decision, not a research project — flat pricing, both semaglutide and tirzepatide, and no scheduled video visit to book around work and pickup.
Visit CoreAge RxMultiMedRx
Ranked #304 · Grade C
Best for: Impossible to budget without a medication price, which the site does not publish.
Visit MultiMedRxThe verdict
CoreAge Rx edges out MultiMedRx on the Rx-Readiness Score, 95 to 34 (A vs C). Working moms who want a decision, not a research project — flat pricing, both semaglutide and tirzepatide, and no scheduled video visit to book around work and pickup.
MultiMedRx is still a genuine option — there is nothing here to budget against. The $100 is a fully refundable consultation fee, the "$45 to start" is an entry promotion, and the program fee that actually covers the medication is described in the FAQ without ever being stated. The FAQ is unusually candid about one thing, though: it calls the charge the "(4-Week monthly) program fee" — four weeks, which is thirteen billing cycles a year rather than twelve. Weigh the six readiness factors below against your own priorities.
Side-by-side on the six factors
Both providers scored on the same readiness rubric — the higher side on each factor is marked. See the methodology.
Price, access & features
| Detail | CoreAge Rx | MultiMedRx |
|---|---|---|
| Rx-Readiness Score | 95/100 · A | 34/100 · C |
| Overall rank | #1 | #304 |
| Semaglutide | $99/mo | No medication price published anywhere |
| Tirzepatide | $149/mo | No medication price published anywhere |
| Coverage | All 50 states | Refuses to publish — "complete the patient intake form" |
| Brand-name access | Compounded only | Compounded only |
| Oral / sublingual | Injection only | Injection only |
CoreAge Rx
Ranked #1 · Grade A
What we like
- Flat monthly price that stays put through titration — no dose-scaling surprise on your busiest month
- Both compounded semaglutide and tirzepatide on one plan, so you're not re-signing to switch
- Async, no-video intake and all-50-states coverage — start it during a lunch break
The caveats
- Not the rock-bottom sticker price — a couple of teaser tiers elsewhere start lower
- Compounded only — no FDA-approved brand option
- General metabolic program, not a boutique concierge service
MultiMedRx
Ranked #304 · Grade C
What we like
- The consultation fee is described as fully refundable and stated up front
- Says what the program fee covers — "up to 10ml for Tirzepatide and 2.5 for Semaglutide"
- No long-term contract required, with a one-month option available
The caveats
- No medication price appears anywhere on the site
- The $100 is a consultation fee and the $45 a promotion; neither is a recurring cost
- Four-week billing, by the site's own phrase — thirteen cycles a year
Assume any provider we list may compensate us — we may earn a commission, at no cost to you. It never changes a Rx-Readiness Score. Pricing, states and verification reflect each provider's public disclosures at last review; the Rx-Readiness Score is our editorial judgment per the methodology. Prices change — confirm on each provider's site. Not medical advice; see our disclosure.
More head-to-heads
Keep comparing CoreAge Rx and MultiMedRx against other providers on our shortlist.
Or browse the full comparison hub.